Cargando…
No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix Vaccination Campaign in Finland
BACKGROUND: Narcolepsy cataplexy syndrome, characterised by excessive daytime sleepiness and cataplexy, is strongly associated with a genetic marker, human leukocyte antigen (HLA) DQB1*06:02. A sudden increase in the incidence of childhood narcolepsy was observed after vaccination with AS03-adjuvant...
Autores principales: | Melén, Krister, Partinen, Markku, Tynell, Janne, Sillanpää, Maarit, Himanen, Sari-Leena, Saarenpää-Heikkilä, Outi, Hublin, Christer, Olsen, Päivi, Ilonen, Jorma, Nohynek, Hanna, Syrjänen, Ritva, Kilpi, Terhi, Vuorela, Arja, Kirjavainen, Turkka, Vaarala, Outi, Julkunen, Ilkka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738560/ https://www.ncbi.nlm.nih.gov/pubmed/23950869 http://dx.doi.org/10.1371/journal.pone.0068402 |
Ejemplares similares
-
AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland
por: Nohynek, Hanna, et al.
Publicado: (2012) -
Antigenic Differences between AS03 Adjuvanted Influenza A (H1N1) Pandemic Vaccines: Implications for Pandemrix-Associated Narcolepsy Risk
por: Vaarala, Outi, et al.
Publicado: (2014) -
No evidence of autoimmunity to human OX(1) or OX(2) orexin receptors in Pandemrix-vaccinated narcoleptic children
por: Melén, Krister, et al.
Publicado: (2020) -
Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1
por: Vuorela, A., et al.
Publicado: (2021) -
Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland
por: Partinen, Markku, et al.
Publicado: (2012)